Hear.com Horizon Go IX vs Lexie B2 Plus

The Hear.com Horizon Go IX is a premium prescription behind-the-ear hearing aid released in 2024, listed at $6,500. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.4/5, ranking #17 among 36 prescription hearing aids tested. This device demonstrates particular strength in speech clarity. Speech in quiet scored a strong 4.0/5, which is +0.72 points above the category average. Speech in noise performance also exceeded the category average by +0.61 points, though at 2.6/5 the absolute score remains mixed—meaning it handles challenging listening environments better than many competitors but still has room for improvement in demanding situations. The most notable limitation is own-voice comfort, scoring 1.8/5—a low result that falls 0.95 points below the category average. Users sensitive to how their own voice sounds may find this particularly noticeable. Feedback handling is strong in absolute terms at 4.4/5, though it sits slightly below the category average by 0.31 points. Music streaming performance is mixed at 2.7/5, essentially matching the category average. At this price point, the Horizon Go IX faces stiff competition. Same-price alternatives like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) deliver higher overall sound performance. Budget-conscious shoppers might also consider options like the Rexton Reach R-Li T80 at Costco, which achieves a higher score at a lower price. The Horizon Go IX is best suited for those prioritizing speech clarity who can accept the own-voice trade-off and prefer the hear.com service model.

The Lexie B2 Plus is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.4/5, placing it in the top 9% of OTC devices tested in our lab. At $899, this behind-the-ear style device delivers strong performance in several key areas while showing some limitations worth considering. In our testing, the Lexie B2 Plus excels in speech clarity for quiet environments, scoring a strong 4.3/5—significantly above the OTC category average by 1.49 points. Own-voice comfort is a particular standout at 4.8/5, well above the category average by 2.29 points, meaning wearers are unlikely to experience the hollow or booming quality of their own voice that can make some hearing aids uncomfortable. Speech in noise performance scores 2.1/5, which is above the OTC category average by 0.58 points but remains mixed in absolute terms—typical for this device class. Music streaming scores 2.6/5, similarly above average by 0.68 points while remaining modest overall. Feedback handling at 2.8/5 falls below the category average by 1.74 points, which may require attention during phone calls or when wearing hats. The Lexie B2 Plus is a solid choice for users prioritizing speech clarity in quieter settings and natural own-voice comfort. It features rechargeable batteries and streaming compatibility with both iPhone and Android devices. This two-time Expert's Choice Award winner (2023, 2024) competes against devices like the higher-scoring Sony CRE-E10 in its price range, but offers a compelling balance of comfort and core speech performance.